Condition
Dysplastic Nevi
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05446155Recruiting
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
NCT00339222Completed
Family Study of Melanoma in Italy
NCT03094273CompletedPrimary
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
NCT00710489Completed
Potential Research Study Participant Registry
NCT03362138Unknown
Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions
Showing all 5 trials